Literature DB >> 3840688

Measurement of ionized calcium in blood platelets with a new generation calcium indicator.

G H Rao, J D Peller, J G White.   

Abstract

Fura 2, a new generation calcium indicator, has a 30 fold brighter fluorescence than Quin 2, shows wavelength shifts upon calcium binding and has a relatively low buffering capacity for free calcium. Quin 2, the most widely used fluorophore, on the other hand, shows no wavelength shifts and has a very high affinity for free calcium. Therefore, we have compared the relative merits of these two fluorophores for monitoring agonist induced alterations in platelet cytosolic calcium. Platelets loaded with Fura 2 showed a significant rise in cytosolic calcium when stirred with agonists such as epinephrine, arachidonate and thrombin, whereas Quin 2 loaded platelets demonstrated a rise in cytosolic calcium only with thrombin stimulation. A rise in agonist induced calcium in Fura 2 loaded platelets was prevented when the cells were exposed first to antagonists such as aspirin or prostaglandin E1. Arachidonate refractory platelets, upon stirring with a single agonist, did not show a significant elevation in cytosolic calcium. However, when refractory platelets were first exposed to epinephrine and then challenged with arachidonate, they revealed a significant elevation in cytosolic calcium. Unlike Quin 2, Fura 2 at the highest concentration tested did not inhibit platelet function. Improved properties of Fura 2 suggest that it may be a useful agent to study agonist induced alterations in cytosolic calcium levels in blood platelets.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840688     DOI: 10.1016/0006-291x(85)91182-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Deliberate quin2 overload as a method for in situ characterization of active calcium extrusion systems and cytoplasmic calcium binding: application to the human platelet.

Authors:  J S Johansson; D H Haynes
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

2.  Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets.

Authors:  K S Authi; G H Rao; B J Evenden; N Crawford
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

3.  Involvement of phosphoinositide metabolism in potentiation by adrenaline of ADP-induced aggregation of rabbit platelets.

Authors:  C Lalau Keraly; J D Vickers; R L Kinlough-Rathbone; J F Mustard
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

4.  Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder.

Authors:  S L Dubovsky; M Thomas; A Hijazi; J Murphy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

5.  Routes of quinolone permeation in Escherichia coli.

Authors:  J S Chapman; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

6.  Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1.

Authors:  K K Hamilton; P J Sims
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.

Authors:  M A Kowalska; A K Rao; J Disa
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

8.  Calpain I activation is not correlated with aggregation in human platelets.

Authors:  J S Elce; L Sigmund; M J Fox
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

9.  A novel, rapid method to quantify intraplatelet calcium dynamics by ratiometric flow cytometry.

Authors:  Alice Assinger; Ivo Volf; Diethart Schmid
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.